SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-022947
Filing Date
2022-02-14
Accepted
2022-02-14 16:35:06
Documents
13
Period of Report
2022-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226748d1_8k.htm   iXBRL 8-K 26922
2 EXHIBIT 99.1 tm226748d1_ex99-1.htm EX-99.1 133788
  Complete submission text file 0001104659-22-022947.txt   346071

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ibio-20220214.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20220214_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20220214_pre.xml EX-101.PRE 22593
7 EXTRACTED XBRL INSTANCE DOCUMENT tm226748d1_8k_htm.xml XML 3474
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 22633183
SIC: 2834 Pharmaceutical Preparations